Australis Capital Archives

Debra BorchardtFebruary 19, 2020

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) terminated a proposed merger with Folium Equity Holding LLC and Folium Merger Sub, LLC. At the time Folium would become a wholly-owned subsidiary of AUSA, and AUSA would be rebranded as and carry on the business of Folium. AUSA said that recently discovered new relevant information with regard […]

William SumnerMay 21, 2019

It’s time for your Daily Hit of cannabis financial news for May 21, 2019. On the Site New Regime Will Impact Aphria Stock No one who follows Aphria Inc. (NYSE: APHA ) stock should have been surprised that the company’s president, Jakob Ripshtein, resigned on May 14. Ever since interim CEO Irwin Simon was appointed Independent Chair […]

Debra BorchardtMay 21, 2019

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) entered into an asset purchase agreement with Green Therapeutics, LLC and affiliated companies, to acquire its Tsunami, Provisions, and GT Flowers cannabis brands in a deal valued at $8 million. The deal is expected to close in late 2019. In addition to the brands, Australis is also buying […]

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

In other news

The Daily Hit: January 4, 2024

Connecticut Attorney General Tells Unlicensed Cannabis Events Company to Stop

Testing Concerns Lead to Quarantine for 70% of Mississippi MMJ Goods

Tag: Australis Capital

Australis Kills Folium Deal

The Daily Hit: May 21, 2019

Australis Capital Acquires Green Therapeutics Brands in $8 Million Deal

The Daily Hit - TEST TEST TEST

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

Get the latest cannabis news delivered right to your inbox

Get the latest cannabis news delivered right to your inbox